Filing Flows

Filing Flows › Health Care › Agape ATP (ATPC)

Agape ATP (ATPC) earnings and revenue breakdown

Latest: Q2 2026 · 10-Q filed Aug 14, 2026 · Agape ATP (ATPC) Q2 2026 earnings results →

Q2 2026 Revenue down 77% year over year to $109K · 140¢ of every $1 of revenue kept as net profit · operating margin -505.0%

Agape ATP made $109K in Q2 2026 (-77% Y/Y): Health and Wellness Services $80K, Product Health Therapies $16K, Skin Care and Health Products Segment $14K. Operating margin -505.0%, net earnings $153K. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 14, 2026.

Revenue$109K
Year over year-77%
Operating margin-505.0%
Net earnings$153K
Operating cash flow−$110K

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $109K in Q2 2026, down 77% year over year and down 60% from the previous quarter. Health and Wellness Services was the largest line at 73% of revenue. Product Health Therapies lost $203K year over year (down 93%), 57% of the total change.

Gross margin was 10.8%, down 3.3 points from Q2 2025. Operating costs exceeded revenue by $551K, an operating margin of -505.0%. Operating expenses fell 18% while revenue fell 77%. Net earnings were $149K. The effective tax rate was -83.0%. Non-operating items added $635K, 759% of pre-tax earnings, so the bottom line overstates operating performance.

Operating cash flow was −$110K. Working capital and other items used $263K.

Quarterly history

Agape ATP revenue by quarterAgape ATP revenue by quarter$360KQ4 2024$289KQ1 2025$465KQ2 2025$371KQ3 2025$399KQ4 2025$274KQ1 2026$109KQ2 2026
Agape ATP net earnings by quarterAgape ATP net earnings by quarter−$827KQ4 2024−$699KQ1 2025−$617KQ2 2025−$595KQ3 2025−$376KQ4 2025−$328KQ1 2026$153KQ2 2026
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q2 202610-QAug 14, 2026$109K-77%-505.0%$153K−$110K
Q1 202610-QMay 15, 2026$274K-5%-247.5%−$328K−$395K
Q4 202510-KApr 13, 2026$399K+11%-325.2%−$376K−$208K
Q3 202510-QNov 13, 2025$371K+12%-162.3%−$595K−$257K
Q2 202510-QAug 13, 2025$465K+49%-133.5%−$617K−$494K
Q1 202510-QMay 15, 2025$289K-9%-249.2%−$699K−$1.5M
Q4 202410-KMar 31, 2025$360K-8%-235.7%−$827K−$645K

Charts

Agape ATP: revenue growth, year over year and quarter over quarterAgape ATP: revenue growth, year over year and quarter over quarterY/YQ/Q-8%Q4 2024-9%-20%Q1 2025+49%+61%Q2 2025+12%-20%Q3 2025+11%+8%Q4 2025-5%-31%Q1 2026-77%-60%Q2 2026
Latest (Q2 2026): Y/Y -77%, Q/Q -60%.
Agape ATP: where the cash came from (+) and went (−), TTM to Q2 2026Agape ATP: where the cash came from (+) and went (−), TTM to Q2 2026Operating cash flow−$970KOther financing$821KCash drawn (+) / kept (−)$165KNet borrowing (+) / repaid (−)−$24KNot reconciled$8KOther investing−$245
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
Agape ATP: profit against cash, quarter by quarterAgape ATP: profit against cash, quarter by quarterNet incomeOperating cash flow−$524K−$425KQ3 2024−$827K−$645KQ4 2024−$699K−$1.5MQ1 2025−$617K−$494KQ2 2025−$595K−$257KQ3 2025−$376K−$208KQ4 2025−$328K−$395KQ1 2026$153K−$110KQ2 2026
Latest (Q2 2026): Net income $153K, Operating cash flow −$110K.
Agape ATP: diluted shares by fiscal year (split-adjusted)Agape ATP: diluted shares by fiscal year (split-adjusted)3.76BFY20203.76BFY2021878MFY202238MFY20231MFY20241MFY2025
-100.0% since FY2020: buybacks shrank the count; earlier years scaled for the 10-for-1 split before FY2025.
Agape ATP in its industry: growth against margin (14 companies, SIC 8000)Agape ATP in its industry: growth against margin (14 companies, SIC 8000)revenue growth, year over year →↑ operating marginmedian +13%median 3%PRVALFSTPIIIPNTGINNVUSPHWGSOMDADCGOTalkspace, Inc.VSEELDDDNPLYATPC (-77%, -100%)
Services-Health Services; dot size is quarterly revenue; dashed lines are the industry's medians.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

About Agape ATP

Agape ATP Corporation, a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on June 1, 2016. Agape ATP Corporation operates through its subsidiaries, namely, Agape ATP Corporation (“AATP LB”), a company incorporated in Labuan, Malaysia, and Agape Superior Living Sdn. Bhd. (“ASL”), a company incorporated in Malaysia on August 8, 2003.

In its own words, from its 10-K, filed Apr 13, 2026.

Agape ATP against its Services-Health Services peers

The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: -77% against the peers' median +13%. Operating margin: -505.0% against the peers' median 5.5%.

CompanyQuarterRevenueY/YOp. margin
ATPC Agape ATPQ2 2026$109K-77%-505.0%
PRVA Privia Health GroupQ3 2026$657M+13%3.1%
LFST LifeStance Health GroupQ3 2026$456M+25%7.3%
PIII P3 Health PartnersQ2 2026$386M+9%10.7%
PNTG Pennant GroupQ3 2026$302M+32%5.5%
INNV InnovAge HoldingQ1 FY27$265M+12%7.6%
USPH U S Physical TherapyQ3 2026$223M+13%11.3%
WGS GeneDx HoldingsQ2 2026$114M+11%-15.3%
OMDA Omada HealthQ3 2026$91.3M+34%5.3%

Source: Agape ATP 10-Q on SEC EDGAR · CIK 1713210 · Services-Health Services

More on ATPC

History

Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results · Q4 2024 results

Compare ATPC with

中文版:Agape ATP(ATPC)财报

Español · Français